333 related articles for article (PubMed ID: 10714647)
1. Cellular proliferative and telomerase activity in canine mammary gland tumors.
Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands.
Griffey SM; Madewell BR; Dairkee SH; Hunt JE; Naydan DK; Higgins RJ
Vet Pathol; 1993 Mar; 30(2):155-61. PubMed ID: 7682368
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression in canine mammary tumors.
Doré M; Lanthier I; Sirois J
Vet Pathol; 2003 Mar; 40(2):207-12. PubMed ID: 12637762
[TBL] [Abstract][Full Text] [Related]
4. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA.
Löhr CV; Teifke JP; Failing K; Weiss E
Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877
[TBL] [Abstract][Full Text] [Related]
7. Telomere length and telomerase activity in canine mammary gland tumors.
Yazawa M; Okuda M; Setoguchi A; Iwabuchi S; Nishimura R; Sasaki N; Masuda K; Ohno K; Tsujimoto H
Am J Vet Res; 2001 Oct; 62(10):1539-43. PubMed ID: 11592316
[TBL] [Abstract][Full Text] [Related]
8. Measurement of telomerase activity in dog tumors.
Yazawa M; Okuda M; Setoguchi A; Nishimura R; Sasaki N; Hasegawa A; Watari T; Tsujimoto H
J Vet Med Sci; 1999 Oct; 61(10):1125-9. PubMed ID: 10563290
[TBL] [Abstract][Full Text] [Related]
9. Expression of bone morphogenetic protein-6 (BMP-6) in myoepithelial cells in canine mammary gland tumors.
Tateyama S; Uchida K; Hidaka T; Hirao M; Yamaguchi R
Vet Pathol; 2001 Nov; 38(6):703-9. PubMed ID: 11732805
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
11. Detection of proliferating cell nuclear antigen (PCNA) in canine and feline mammary tumours.
Preziosi R; Sarli G; Benazzi C; Marcato PS
J Comp Pathol; 1995 Nov; 113(4):301-13. PubMed ID: 8746954
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of telomerase in canine mammary tissues by immunohistochemical analysis and a polymerase chain reaction-based enzyme-linked immunosorbent assay.
Panarese S; Brunetti B; Sarli G
J Vet Diagn Invest; 2006 Jul; 18(4):362-8. PubMed ID: 16921875
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor isoform analysis by quantitative real-time polymerase chain reaction in formalin-fixed, paraffin-embedded canine mammary dysplasias and tumors.
Guil-Luna S; Stenvang J; Brünner N; Sánchez-Céspedes R; Millán Y; Gómez-Laguna J; de las Mulas JM
Vet Pathol; 2014 Sep; 51(5):895-902. PubMed ID: 24249219
[TBL] [Abstract][Full Text] [Related]
14. Detection of matrix metalloproteinases in canine mammary tumours: analysis by immunohistochemistry and zymography.
Hirayama K; Yokota H; Onai R; Kobayashi T; Kumata T; Kihara K; Okamoto M; Sako T; Nakade T; Izumisawa Y; Taniyama H
J Comp Pathol; 2002 Nov; 127(4):249-56. PubMed ID: 12443732
[TBL] [Abstract][Full Text] [Related]
15. Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?
Zavlaris M; Angelopoulou K; Vlemmas I; Papaioannou N
Anticancer Res; 2009 Jan; 29(1):319-25. PubMed ID: 19331168
[TBL] [Abstract][Full Text] [Related]
16. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
[TBL] [Abstract][Full Text] [Related]
17. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
18. Expression of a tumor-associated antigen, RCAS1, in canine mammary tumors.
Okamura Y; Haraguchi T; Morimoto M; Okuda M; Une S; Nakaichi M; Taura Y
J Vet Med Sci; 2004 Jun; 66(6):651-8. PubMed ID: 15240939
[TBL] [Abstract][Full Text] [Related]
19. A first immunohistochemistry study of transketolase and transketolase-like 1 expression in canine hyperplastic and neoplastic mammary lesions.
Burrai GP; Tanca A; Cubeddu T; Abbondio M; Polinas M; Addis MF; Antuofermo E
BMC Vet Res; 2017 Jan; 13(1):38. PubMed ID: 28143530
[TBL] [Abstract][Full Text] [Related]
20. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
Ferreira E; Gobbi H; Saraiva BS; Cassali GD
Vet Pathol; 2012 Mar; 49(2):322-9. PubMed ID: 21282668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
